Immunotherapy for Bladder Cancer: Latest Advances and Ongoing Clinical Trials
Sign Up to like & getrecommendations! Published in 2022 at "Immunological Investigations"
DOI: 10.1080/08820139.2022.2118606
Abstract: ABSTRACT For nearly 50 years, immunotherapy has been used in patients with bladder cancer in the form of Mycobacterium bovis Bacillus Calmette-Guerin (BCG), which is still the first-line therapy for non-muscle invasive disease. However, the remarkable… read more here.
Keywords: immunotherapy bladder; latest advances; bladder cancer; cancer latest ... See more keywords
Myeloid Resistance is not Futile: Biomarkers of Immunotherapy in Bladder Cancer
Sign Up to like & getrecommendations! Published in 2021 at "Clinical Cancer Research"
DOI: 10.1158/1078-0432.ccr-21-1011
Abstract: The majority of patients with urothelial cancer do not respond to immune checkpoint blockade directed at the PD-(L)1 axis. Recently, robust profiling data were used to derive predictive biomarker signatures for both protumorigenic immunity and… read more here.
Keywords: myeloid resistance; resistance futile; immunotherapy bladder; futile biomarkers ... See more keywords